WebDisclosure WebDisclosure
Basculer en Français
10371 Companies
216166 Keywords
145880 Articles
114460 Press releases
Headlines Articles Press releases AL-S Pharma AG Remove
  1. Home
  2. Companies
  3. AL-S Pharma AG
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 03/19/2026 at 07:35, 1 month 21 days ago

    AL-S Pharma's AP-101 Shows Promise in ALS Treatment

    Clinical Trial ALS Treatment Phase 2 Data AP-101 SOD1 Targeting
  • BRIEF

    published on 03/19/2026 at 07:35, 1 month 21 days ago

    Le traitement AP-101 d'AL-S Pharma se révèle prometteur dans le traitement de la SLA.

    Essai Clinique Traitement De La SLA Données De La Phase 2 AP-101 Ciblage SOD1
  • PRESS RELEASE

    published on 03/19/2026 at 07:30, 1 month 21 days ago

    Additional Phase 2 Data of AL-S Pharma’s Lead Program AP-101 Further Demonstrate Clinically Meaningful Disease Modification and Prolonged Survival in ALS

    AL-S Pharma AG presents additional Phase 2 data of lead program AP-101 at AD/PD International Conference showing disease modification in ALS patients. AP-101 targets misfolded SOD1 to inhibit disease progression
    ALS Phase 2 Data AP-101 AL-S Pharma AG SOD1
    Logo of AL-S Pharma AG
Accesswire
  • Published on 05/09/2026 at 01:55, 14 hours 37 minutes ago

    Prospect Ridge Announces Board Resignation

  • Published on 05/09/2026 at 01:40, 14 hours 52 minutes ago

    Findev Inc. Issues Corrective Disclosure

  • Published on 05/09/2026 at 01:30, 15 hours 2 minutes ago

    Star Copper Announces Agreement with Zimtu Capital Corp.

  • Published on 05/09/2026 at 00:00, 16 hours 32 minutes ago

    Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology

  • Published on 05/08/2026 at 23:01, 17 hours 31 minutes ago

    Water Ways Announces Corporate Updates

View all ACCESSWIRE
EQS Group
  • Published on 05/08/2026 at 20:38, 19 hours 54 minutes ago

    EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary Figures for Q2/6M 2025/26; Order Intake Above Expectations and Previous Year ; Sales and Earnings below Market Expectations

  • Published on 05/08/2026 at 19:12, 21 hours 19 minutes ago

    EQS-Adhoc: Viromed Medical AG missed revenue forecast for 2025 financial year, but continued to grow significantly and achieved a positive result; revised forecast for 2026

  • Published on 05/08/2026 at 19:02, 21 hours 30 minutes ago

    Metall Zug – Annual General Meeting of Shareholders approves all proposals

  • Published on 05/08/2026 at 18:29, 22 hours 3 minutes ago

    Designated Person Notification

  • Published on 05/08/2026 at 18:29, 22 hours 3 minutes ago

    Designated Person Notification

View all EQS
Les Echos
  • Published on 05/07/2026 at 19:15, 1 day 21 hours ago

    2026 Annual General Meeting: approval of all resolutions submitted to the Meeting

  • Published on 05/07/2026 at 19:15, 1 day 21 hours ago

    Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote

  • Published on 05/07/2026 at 19:06, 1 day 21 hours ago

    Disclosure of Share Capital and Voting Rights as of April 30, 2026

  • Published on 05/07/2026 at 19:06, 1 day 21 hours ago

    Déclaration du nombre d’actions et droits de vote au 30 avril 2026

  • Published on 05/07/2026 at 19:00, 1 day 21 hours ago

    ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy